“Peter Kolchinsky”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  4/25/24  as  ↓Group Member

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Peter Kolchinsky” has been a Group Member with  2  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
4/25/24		MA	Ra Capital Management, L.P.	810	SC 13G	NY	Protara Therapeutics, Inc.
12/14/18		MA	RA Capital Healthcare Fund LP	2	SC 13D/A	MA	Ra Pharmaceuticals, Inc.

“Peter Kolchinsky” has/had a Group Member interest in  255  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
4/25/24		NY	Protara Therapeutics, Inc.	6	SC 13G	MA	Ra Capital Management, L.P.
4/15/24		CA	Surrozen, Inc./DE	1	SC 13G	MA	Ra Capital Management, L.P.
4/12/24		DE	Eliem Therapeutics, Inc.	5	SC 13D/A	MA	Ra Capital Management, L.P.
4/12/24		CA	Boundless Bio, Inc.	1	SC 13G	MA	Ra Capital Management, L.P.
4/11/24		MA	CervoMed Inc.	1	SC 13G	MA	Ra Capital Management, L.P.
4/11/24		MA	Acrivon Therapeutics, Inc.	3	SC 13D/A	MA	Ra Capital Management, L.P.
4/4/24		MA	Dyne Therapeutics, Inc.	4	SC 13G	MA	Ra Capital Management, L.P.
4/1/24		UT	Sera Prognostics, Inc.	1	SC 13G	MA	Ra Capital Management, L.P.
3/29/24		CA	Nkarta, Inc.	3	SC 13D/A	MA	Ra Capital Management, L.P.
3/29/24		CA	ARS Pharmaceuticals, Inc.	5	SC 13D/A	MA	Ra Capital Management, L.P.
3/29/24		CA	Alto Neuroscience, Inc.	1	SC 13G	MA	Ra Capital Management, L.P.
3/28/24		CA	LENZ Therapeutics, Inc.	1	SC 13D	MA	Ra Capital Management, L.P.
3/25/24		CA	Regulus Therapeutics Inc.	5	SC 13G	MA	Ra Capital Management, L.P.
3/25/24			Cybin Inc.	1	SC 13G	MA	Ra Capital Management, L.P.
3/11/24		MA	PepGen Inc.	4	SC 13D/A	MA	Ra Capital Management, L.P.
3/6/24		CA	Janux Therapeutics, Inc.	2	SC 13D/A	MA	Ra Capital Management, L.P.
3/6/24		CA	89bio, Inc.	9	SC 13D/A	MA	Ra Capital Management, L.P.
2/27/24			Connect Biopharma Holdings Ltd.	6	SC 13D/A	MA	Ra Capital Management, L.P.
2/26/24		PA	Larimar Therapeutics, Inc.	4	SC 13G	MA	Ra Capital Management, L.P.
2/22/24		CA	Cytek Biosciences, Inc.	5	SC 13G	MA	Ra Capital Management, L.P.
			More...  Please Sign In to list all 255 of them.

“Peter Kolchinsky” has been a Group Member with  10  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
4/25/24		MA	Ra Capital Healthcare Fund, L.P.	638	SC 13G	MA	Ra Capital Management, L.P.	NY	Protara Therapeutics, Inc.
		MA	Rajeev Shah	418
2/13/24		MA	Ra Capital Nexus Fund, II L.P.	2	SC 13D/A	MA	Ra Capital Management, L.P.	MA	PepGen Inc.
9/29/23		MA	Ra Capital H Ealthcare Fund, L.P.	2	SC 13G	MA	Ra Capital Management, L.P.	NC	Chimerix Inc.
12/14/18		MA	RA Capital Management, LLC	2	SC 13D/A	MA	RA Capital Healthcare Fund LP	MA	Ra Pharmaceuticals, Inc.
2/16/10		MA	Ra Capital Healthcare Fund II, L.P.	24	SC 13G/A	MA	Ra Capital Management, L.P.	CA	Ardea Biosciences, Inc./DE
1/5/09		•	Ra Capital Heahthcare Fund II, L.P.	1	SC 13G	MA	Ra Capital Management, L.P.	CA	Ardea Biosciences, Inc./DE
12/15/08		•	Aldrich, Richard H.	48	SC 13D/A	MA	Ra Capital Management, L.P.	WA	Northstar Neuroscience, Inc.
7/15/08		MA	Ra Capital Biotech Fund II, L.P.	29	SC 13G	MA	Ra Capital Management, L.P.	MA	Arqule Inc.
		MA	R.A. Capital Biotech Fund, L.P.	46

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Peter Kolchinsky” has been a Signatory for/with  29  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
4/25/24		MA	Ra Capital Management, L.P.	403	SC 13G	NY	Protara Therapeutics, Inc.
4/24/24		CA	Cidara Therapeutics, Inc.	1	8-K	—
4/11/24		DE	Eliem Therapeutics, Inc.	3	DEFA14A	—
3/28/24		MA	CervoMed Inc.	1	8-K	—
3/21/24		CA	LENZ Therapeutics, Inc.	1	8-K	—
4/20/23		CA	ARS Pharmaceuticals, Inc.	3	S-3	—
2/2/23		PA	Mineralys Therapeutics, Inc.	3	S-1/A	—
12/7/22		MA	Vor Biopharma Inc.	2	8-K	—
11/10/22		NV	Research Alliance Corp. II	10	10-Q	—
10/17/22		MA	Acrivon Therapeutics, Inc.	2	S-1	—
9/1/22		MA	Forma Therapeutics Holdings, Inc.	7	8-K	—
6/13/22			DBV Technologies S.A.	1	8-K	—
4/6/22		MA	HilleVax, Inc.	2	S-1	—
9/30/21		MA	Pyxis Oncology, Inc.	1	S-1/A	—
9/9/21		CA	Tyra Biosciences, Inc.	1	S-1/A	—
9/9/21		CA	DICE Therapeutics, Inc.	2	S-1/A	—
7/2/21		CA	Cytek Biosciences, Inc.	2	S-1	—
6/9/21		IN	POINT Biopharma Global Inc.	9	424B3	—
5/24/21		CA	Day One Biopharmaceuticals, Inc.	3	S-1/A	—
2/26/21			Connect Biopharma Holdings Ltd.	2	F-1	—
			More...  Please Sign In to list all 29 of them.

“Peter Kolchinsky” has/had a Signatory interest in  148  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
4/25/24		NY	Protara Therapeutics, Inc.	1	SC 13G	MA	Ra Capital Management, L.P.
4/15/24		CA	Surrozen, Inc./DE	1	SC 13G	MA	Ra Capital Management, L.P.
4/12/24		DE	Eliem Therapeutics, Inc.	5	SC 13D/A	MA	Ra Capital Management, L.P.
4/12/24		CA	Boundless Bio, Inc.	1	SC 13G	MA	Ra Capital Management, L.P.
4/4/24		MA	Dyne Therapeutics, Inc.	4	SC 13G	MA	Ra Capital Management, L.P.
4/1/24		UT	Sera Prognostics, Inc.	1	SC 13G	MA	Ra Capital Management, L.P.
3/29/24		CA	Alto Neuroscience, Inc.	1	SC 13G	MA	Ra Capital Management, L.P.
3/28/24		CA	LENZ Therapeutics, Inc.	1	SC 13D	MA	Ra Capital Management, L.P.
3/25/24		CA	Regulus Therapeutics Inc.	1	SC 13G	MA	Ra Capital Management, L.P.
3/25/24			Cybin Inc.	1	SC 13G	MA	Ra Capital Management, L.P.
3/11/24		MA	PepGen Inc.	4	SC 13D/A	MA	Ra Capital Management, L.P.
3/6/24		CA	Janux Therapeutics, Inc.	2	SC 13D/A	MA	Ra Capital Management, L.P.
3/6/24		CA	89bio, Inc.	8	SC 13D/A	MA	Ra Capital Management, L.P.
2/27/24			Connect Biopharma Holdings Ltd.	6	SC 13D/A	MA	Ra Capital Management, L.P.
2/26/24		PA	Larimar Therapeutics, Inc.	4	SC 13G	MA	Ra Capital Management, L.P.
2/22/24		CA	Cytek Biosciences, Inc.	5	SC 13G	MA	Ra Capital Management, L.P.
2/21/24		WA	Icosavax, Inc.	3	SC 13D/A	MA	Ra Capital Management, L.P.
2/14/24		MA	EyePoint Pharmaceuticals, Inc.	3	SC 13G/A	MA	Ra Capital Management, L.P.
2/14/24		CA	Unicycive Therapeutics, Inc.	2	SC 13G/A	MA	Ra Capital Management, L.P.
2/14/24			Orchard Therapeutics plc	5	SC 13G/A	MA	Ra Capital Management, L.P.
			More...  Please Sign In to list all 148 of them.